1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors

Details for Australian Patent Application No. 2002257459 (hide)

Owner Merck Frosst Canada Ltd.

Inventors Hamel, Pierre; Friesen, Richard; Li, Chun; Guay, Daniel; Laliberte, Sebastien; Girard, Mario; Girard, Yves

Agent Spruson & Ferguson

Pub. Number AU-B-2002257459

PCT Pub. Number WO2002/094823

Priority 60/293,247 24.05.01 US

Filing date 22 May 2002

Wipo publication date 3 December 2002

Acceptance publication date 14 December 2006

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4375 (2006.01)

A61K 31/444 (2006.01)

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/04 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 11/08 (2006.01) Drugs for disorders of the respiratory system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 27/16 Drugs for disorders of the senses

Event Publications

8 May 2003 Application Open to Public Inspection

  Published as AU-B-2002257459

16 March 2006 Assignment before Grant

  Merck Frosst Canada & Co. The application has been assigned to Merck Frosst Canada Ltd.

14 December 2006 Application Accepted

  Published as AU-B-2002257459

19 April 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002257460-ION EXCHANGE MEMBRANES AND DISSOLVED GAS SENSORS

2002257458-MAGE-A1 PEPTIDES FOR TREATING OR PREVENTING CANCER